X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211146
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211024
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-tentative-usfda-approval-for-depressive-disorder-drug/articleshow/88749257.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211066
https://news.cision.com/h--lundbeck-a-s/r/vortioxetine-significantly-improves-overall-functioning-in-a-global-real-world-study-in-major-depres,c3330732
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210953
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212631
http://www.pmlive.com/pharma_news/lundbecks_key_products_shine_in_q2_but_problems_remain_1297435
https://health.economictimes.indiatimes.com/news/pharma/dcgi-approves-brintellix-in-india-for-major-depressive-disorder/66170465
https://health.economictimes.indiatimes.com/news/pharma/dcgi-approves-brintellix-in-india-for-major-depressive-disorder/66170465
https://seekingalpha.com/news/3393728-takeda-files-marketing-application-japan-mdd-med-vortioxetine
https://globenewswire.com/news-release/2018/09/28/1586313/0/en/Takeda-and-Lundbeck-submit-New-Drug-Application-NDA-for-vortioxetine-in-Japan-for-the-treatment-of-Major-Depressive-Disorder-MDD.html?print=1
https://www.pharmacompass.com/pdf/news/trintellix-vortioxetine-hydrobromide-h-lundbeck-as-takeda-pharmaceutical-company-ltd-v-apicore-us-llc-1531725337.pdf
https://www.pharmacompass.com/pdf/news/trintellix-vortioxetine-hydrobromide-h-lundbeck-v-torrent-pharma-1525670914.pdf
https://www.pharmacompass.com/pdf/news/trintellix-vortioxetine-hydrobromide-h-lundbeck-v-sigmapharm-lab-1525671054.pdf
https://www.pharmacompass.com/pdf/news/trintellix-vortioxetine-h-lundbeck-v-amneal-pharmaceuticals-1517811630.pdf
https://www.pharmacompass.com/pdf/news/trintellix-vortioxetine-h-lundbeck-v-hetero-usa-1517811527.pdf
https://www.pharmacompass.com/pdf/news/trintellix-vortioxetineh-lundbeck-v-sandoz-1517811354.pdf
https://www.pharmacompass.com/pdf/news/Trintellix-Vortioxetine-Hcl-H-Lundbeck-v-Zydus-Pharmaceuticals-USA-1517316603.pdf
https://www.pharmacompass.com/pdf/news/Trintellix-Vortioxetine-Hydrobromide-H-Lundbeck-V-Zydus-Pharma-USA-1517228283.pdf
https://www.pharmacompass.com/pdf/news/trintellix-vortioxetine-hydrobromide-h-lundbeck-v-cipla-limited-1517228167.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-trintellix-vortioxetine-tablets-1512711166.pdf
https://globenewswire.com/news-release/2017/06/23/1028313/0/en/Lundbeck-and-Takeda-receive-Complete-Response-Letter-from-the-FDA-for-Trintellix-vortioxetine-sNDA.html
http://www.in-pharmatechnologist.com/Processing/Takeda-inaugurates-100m-German-oral-solid-dose-plant
http://www.fiercebiotech.com/biotech/lundbeck-takeda-drug-fails-to-best-placebo-adhd-phii
http://www.prnewswire.com/news-releases/trintellix-vortioxetine-now-available-in-us-pharmacies-300277786.html
http://www.fiercepharma.com/marketing/a-name-change-switcheroo-fda-chooses-trintellix-for-takeda-s-brintellix
http://www.fiercebiotech.com/story/lundbeck-slides-after-fda-rejects-label-claim-against-adcomm-recommendation/2016-03-31
http://www.pharmatimes.com/Article/16-03-30/FDA_rejects_Brintellix_label_expansion_for_cognitive_symptoms.aspx
http://www.prnewswire.com/news-releases/takeda-and-lundbeck-receive-complete-response-letter-for-brintellix-vortioxetine-snda-300242296.html
http://uk.reuters.com/article/us-h-lundbeck-fda-idUKKCN0VD0TE?rpc=401
http://www.pharmatimes.com/Article/15-11-26/NICE_backs_new_therapies_for_depression_melanoma.aspx
http://pharmatimes.com/Article/15-08-11/Lundbeck_Takeda_file_cognitive_data_for_Brintellix_with_FDA.aspx
http://www.biospectrumasia.com/biospectrum/news/222129/fda-review-takedas-depression-drug
http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=124886&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Pharmaceutical-News+%28PW+-+News+-+Pharma+News%29#.VcmTlXGqqko
http://consumerist.com/2015/07/30/fda-warns-about-mixups-between-drugs-with-similar-names/?
Market Place
Share 
